Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever

Salerno-Gonçalves R. et al, (2022), Cellular Immunology, 378

Addressing vaccine inequities among Ukrainian refugees.

Hill M. et al, (2022), Lancet Infect Dis, 22, 935 - 936

Effect of childhood vaccination and antibiotic use on pneumococcal populations and genome-wide associations with disease among children in Nepal: an observational study.

Kandasamy R. et al, (2022), Lancet Microbe, 3, e503 - e511

Systematic review of host genomic biomarkers of invasive bacterial disease: Distinguishing bacterial from non-bacterial causes of acute febrile illness.

Kelly E. et al, (2022), EBioMedicine, 81

Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials

Billard MN. et al, (2022), Journal of Clinical Epidemiology, 147, 11 - 20

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.

Marchevsky NG. et al, (2022), EBioMedicine, 81

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.

Sheerin D. et al, (2022), Cell Biosci, 12

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.

Li G. et al, (2022), Lancet, 399, 2212 - 2225

Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.

Rollier CS. et al, (2022), Vaccine

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.

Tuekprakhon A. et al, (2022), Cell

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

Li Y. et al, (2022), The Lancet, 399, 2047 - 2064

Viral vector vaccines.

McCann N. et al, (2022), Curr Opin Immunol, 77

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.

Nutalai R. et al, (2022), Cell

Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial

MAIDEN M. et al, (2022), Vaccine

Future reporting of vaccine uptake needs to include any change in ethnic or socioeconomic disparities.

Hoang U. et al, (2022), BMJ, 377

Innovative vaccine approaches—a Keystone Symposia report

Cable J. et al, (2022), Annals of the New York Academy of Sciences, 1511, 59 - 86

Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank.

Mentzer AJ. et al, (2022), Nat Commun, 13

National rates and disparities in childhood vaccination and vaccine-preventable disease during the COVID-19 pandemic: English sentinel network retrospective database study.

Hoang U. et al, (2022), Arch Dis Child

Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR.

Ratcliff J. et al, (2022), J Clin Microbiol

Decoupling of omicron variant infections and severe COVID-19

Madhi SA. et al, (2022), The Lancet, 399, 1047 - 1048

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?